|
|
|
Insider
Information: |
Soni Manmeet Singh |
Relationship: |
Chief Operating Office... |
City: |
Sunnyvale |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
2,982,092 |
|
Indirect Shares
|
83 |
|
|
Direct
Value |
$14,533,591 |
|
|
Indirect Value
|
$12,275 |
|
|
Total
Shares |
2,982,175 |
|
|
Total
Value |
$14,545,866 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
7
|
Stock
price went up :
|
1
|
7
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
7.0
|
Percentage
Gain/Loss : |
53.8%
|
539.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Pharmacyclics Inc |
PCYC |
Chief Financial Officer |
2015-05-26 |
0 |
2013-04-30 |
0 |
Premium* |
|
Alnylam Pharmaceuticals Inc |
ALNY |
Chief Financial Officer |
2017-07-25 |
0 |
2018-07-10 |
83 |
Premium* |
|
Arena Pharmaceuticals Inc |
ARNA |
Director |
2020-06-17 |
5,902 |
2018-12-14 |
0 |
Premium* |
|
Reata Pharmaceuticals Inc |
RETA |
COO, CFO and President |
2023-09-26 |
0 |
2020-08-14 |
0 |
Premium* |
|
Summit Therapeutics Inc |
SMMT |
Chief Operating Office... |
2023-10-13 |
2,976,190 |
2023-10-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RETA |
Reata Pharmaceuticals Inc |
COO and CFO |
|
2021-12-31 |
4 |
B |
$26.22 |
$419,565 |
D/D |
16,000 |
19,000 |
2.74 |
% |
|
SMMT |
Summit Therapeutics Inc |
Chief Operating Officer |
|
2023-10-13 |
4 |
B |
$1.68 |
$4,999,999 |
D/D |
2,976,190 |
2,976,190 |
2.81 |
% |
|
PCYC |
Pharmacyclics Inc |
Chief Financial Officer |
|
2015-03-03 |
4 |
D |
$216.77 |
$560,121 |
D/D |
(2,584) |
58,027 |
0 |
- |
|
PCYC |
Pharmacyclics Inc |
Chief Financial Officer |
|
2015-05-26 |
4 |
D |
$261.25 |
$228,071 |
D/D |
(873) |
0 |
0 |
- |
|
PCYC |
Pharmacyclics Inc |
Chief Financial Officer |
|
2015-05-26 |
4 |
D |
$261.25 |
$14,107,500 |
D/D |
(54,000) |
873 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
COO, CFO and President |
|
2023-09-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(62,621) |
0 |
0 |
- |
|
PCYC |
Pharmacyclics Inc |
Chief Financial Officer |
|
2014-11-13 |
4 |
OE |
$61.60 |
$61,600 |
D/D |
1,000 |
39,611 |
0 |
- |
|
PCYC |
Pharmacyclics Inc |
Chief Financial Officer |
|
2015-03-11 |
4 |
OE |
$61.60 |
$1,808,849 |
D/D |
24,098 |
82,125 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
COO, CFO and President |
|
2023-06-13 |
4 |
OE |
$27.32 |
$683,000 |
D/D |
25,000 |
136,461 |
0 |
- |
|
PCYC |
Pharmacyclics Inc |
Chief Financial Officer |
|
2014-11-13 |
4 |
S |
$141.44 |
$141,442 |
D/D |
(1,000) |
38,611 |
0 |
- |
|
PCYC |
Pharmacyclics Inc |
Chief Financial Officer |
|
2015-03-11 |
4 |
S |
$254.15 |
$6,124,507 |
D/D |
(24,098) |
58,027 |
0 |
- |
|
PCYC |
Pharmacyclics Inc |
Chief Financial Officer |
|
2015-03-13 |
4 |
S |
$254.88 |
$870,756 |
D/D |
(3,416) |
54,611 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
COO, CFO and President |
|
2023-03-03 |
4 |
S |
$87.97 |
$315,548 |
D/D |
(3,587) |
88,926 |
0 |
% |
|
RETA |
Reata Pharmaceuticals Inc |
COO, CFO and President |
|
2023-03-07 |
4 |
S |
$84.70 |
$52,680 |
D/D |
(622) |
88,304 |
0 |
% |
|
RETA |
Reata Pharmaceuticals Inc |
COO, CFO and President |
|
2023-05-15 |
4 |
S |
$84.32 |
$1,818,567 |
D/D |
(21,507) |
116,797 |
0 |
% |
|
RETA |
Reata Pharmaceuticals Inc |
COO, CFO and President |
|
2023-05-16 |
4 |
S |
$80.93 |
$50,584 |
D/D |
(625) |
116,172 |
0 |
% |
|
RETA |
Reata Pharmaceuticals Inc |
COO, CFO and President |
|
2023-06-12 |
4 |
S |
$99.62 |
$469,297 |
D/D |
(4,711) |
111,461 |
0 |
% |
|
RETA |
Reata Pharmaceuticals Inc |
COO, CFO and President |
|
2023-06-13 |
4 |
S |
$99.75 |
$8,034,343 |
D/D |
(78,085) |
58,376 |
0 |
% |
|
RETA |
Reata Pharmaceuticals Inc |
COO, CFO and President |
|
2023-08-16 |
4 |
S |
$168.41 |
$295,566 |
D/D |
(1,755) |
62,621 |
0 |
% |
|
44 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|